Decrease in eosinophilia as a marker of response to therapy in solid organ transplant candidates with Strongyloides infection: A single-center experience

Transpl Infect Dis. 2018 Oct;20(5):e12954. doi: 10.1111/tid.12954. Epub 2018 Jul 4.

Authors

Jacques Simkins¹, Shweta Anjan¹, Jose Fernando Camargo¹

Affiliation

¹ Department of Medicine/Division of Infectious Diseases, University of Miami School of Medicine, Miami, FL, USA.

PMID: 29896920
DOI: 10.1111/tid.12954

No abstract available

Keywords: Strongyloides; eosinophilia; ivermectin; solid organ transplant.

Publication types

Letter

MeSH terms

Adult
Aged
Animals
Antiparasitic Agents / administration & dosage
Antiparasitic Agents / therapeutic use*
Biomarkers / blood
Eosinophilia / blood*
Eosinophilia / drug therapy
Eosinophils / drug effects*
Female
Humans
Ivermectin / administration & dosage
Ivermectin / therapeutic use
Leukocyte Count
Male
Middle Aged
Organ Transplantation / adverse effects*
Strongyloides stercoralis / drug effects*
Strongyloidiasis / complications
Strongyloidiasis / drug therapy*

Substances

Antiparasitic Agents
Biomarkers
Ivermectin